价格

antiviral kinase

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Methods for enhancing the production of viral vaccines in cell culture
US 7132271 B2申请人: UNIV CALIFORNIA优先权: 2000
US
6 件公开
Sesquiterpenoid derivative and use thereof in preparing broad-spectrum antiviral drug
US 12258351 B2申请人: UNIV KUNMING SCIENCE & TECHNOLOGY优先权: 2022
CN
US
WO
4 件公开
Screening methods to identify agents that selectively inhibit hepatitis C virus replication
US 7148006 B2申请人: UNIV WASHINGTON优先权: 2000
US
3 件公开
Pan-antiviral peptides for protein kinase inhibition
- US 9220743 B2
  申请人: MILLER KENT D优先权: 2010
  US
  3 件公开
- US 7807635 B1
  申请人: MILLER KENT D优先权: 2010
  US
Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus (HIV)-infected cells
US 12228572 B2申请人: FIRST HOSPITAL CHINA MEDICAL UNIV优先权: 2021
EP
US
2 件公开
USE OF COMBINATION OF LSD1 INHIBITOR AND DRUG TO TREAT CANCER
WO 2024213057 A1申请人: SHANGHAI INST MATERIA MEDICA CAS优先权: 2023
CN
WO
2 件公开
USE OF YAP PATHWAY ACTIVATOR IN PREPARATION OF ANTI-HEPATOTROPIC VIRUS MEDICAMENT
WO 2025247037 A1申请人: UNIV FUDAN优先权: 2024
CN
WO
2 件公开
Clusianon isomers and use thereof
US 7135501 B2申请人: SEEBER SIEGFRIED优先权: 2001
US
2 件公开
Substituted bicylo[3.3.1]nonan-2,4,9-triones as pharmaceutical active ingredients
US 7199161 B2申请人: DIAGENICS INTERNAT CORP优先权: 2001
US
2 件公开
Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy
US 7504205 B2申请人: BURNHAM INST优先权: 2005
US
2 件公开

药物

antiviral kinase

专利

Pan-antiviral peptides for protein kinase inhibition